Top Markets
Coin of the day
ShanXi C&Y Pharmaceutical Group Co., Ltd. ShanXi C&Y Pharmaceutical Group Co., Ltd.

ShanXi C&Y Pharmaceutical Group Co., Ltd.

300254
Rank in Stocks #15734
ShanXi C&Y Pharmaceutical Group Co., Ltd. is a global pharmaceutical enterprise... ShanXi C&Y Pharmaceutical Group Co., Ltd. is a global pharmaceutical enterprise dedicated to the research, development, production, and distribution of a diverse range of medicines. Its operations span key markets including China, the United States, and Hong Kong, alongside other international regions. The company's extensive product catalog features specialized solutions for maternal and infant care, urological health, and infectious diseases, as well as traditional Chinese remedies and dermatological treatments. Additionally, it diversifies its offerings with tea bag products. Founded in 2005, the organization underwent a name change in September 2014, evolving from Shanxi C&Y Pharmaceutical Co., Ltd. to its current designation. ShanXi C&Y Pharmaceutical Group Co., Ltd. maintains its corporate headquarters in Shanghai, China.
Share Price
$1.30
Market Cap
$333.97M
Change (1 day)
0.45%
Change (1 year)
-19.21%
Country
CN
Trade ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254)

Category

P/E ratio for ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254)
P/E ratio as of 2026 TTM: 0
According to ShanXi C&Y Pharmaceutical Group Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for ShanXi C&Y Pharmaceutical Group Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.